Is it normal to take progesterone (a hormone) continuously every day without having periods (amenorrhea) for endometrial protection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Continuous Progesterone for Endometrial Protection Without Periods

Yes, taking progesterone continuously every day without having periods (amenorrhea) is a normal and medically appropriate regimen for endometrial protection when combined with estrogen therapy. 1, 2

Understanding Continuous vs. Sequential Regimens

There are two standard approaches to progesterone administration for endometrial protection, and both are medically appropriate:

Sequential (Cyclical) Regimen

  • Progesterone is taken 12-14 days per month (typically 200 mg oral micronized progesterone daily) 3, 4
  • This regimen induces withdrawal bleeding similar to a menstrual period each month 1, 2
  • The bleeding occurs after stopping progesterone at the end of each cycle 5

Continuous Combined Regimen

  • Progesterone is taken every single day without interruption (typically 100 mg oral micronized progesterone daily or 2.5 mg medroxyprogesterone acetate daily) 2, 5
  • This regimen is specifically designed to induce amenorrhea (no periods) 2, 5
  • Amenorrhea rates reach 88-93% by 3-6 months of continuous therapy 5
  • This is the preferred approach for women who wish to avoid monthly bleeding 6, 5

Why Continuous Progesterone Causes Amenorrhea

The continuous presence of progesterone fully suppresses endometrial proliferation and prevents the buildup-and-shedding cycle that causes bleeding. 5 When progesterone is given daily at lower doses (100 mg vs. 200 mg for sequential regimens), it maintains the endometrium in a quiescent, non-proliferative state with inhibited mitoses, resulting in no withdrawal bleeding. 5

Endometrial Protection is Maintained

Both regimens provide complete endometrial protection against hyperplasia and cancer when used correctly: 3, 4

  • Sequential regimen: 200 mg oral micronized progesterone for 12-14 days per month provides proven endometrial protection for up to 5 years 4
  • Continuous regimen: 100 mg oral micronized progesterone daily (given 25 days per month or continuously) provides equivalent endometrial protection and induces amenorrhea in over 90% of women 5
  • In clinical trials, only 6% of women on progesterone plus estrogen developed hyperplasia compared to 64% on estrogen alone 3

What to Expect with Continuous Progesterone

Initial spotting or bleeding is common but typically resolves: 5, 7

  • During the first 3-6 months, irregular spotting or breakthrough bleeding may occur 8
  • By 6-12 months, amenorrhea rates exceed 90% with minimal to no bleeding episodes 5, 7
  • Isolated spotting episodes may occur in some women but do not indicate treatment failure 7

Critical Dosing for Continuous Regimens

The minimum effective doses for continuous progesterone regimens are: 2, 5

  • Oral micronized progesterone: 100 mg daily continuously 2, 5
  • Medroxyprogesterone acetate: 2.5 mg daily continuously 2
  • Dydrogesterone: 5 mg daily continuously 2

These lower daily doses (compared to sequential regimens) are sufficient because the progesterone is present continuously without hormone-free intervals. 5

When to Be Concerned

Contact your healthcare provider if you experience: 3

  • Heavy or persistent bleeding after the first 6 months of continuous therapy 8
  • Any bleeding that seems abnormal or concerning to you 3
  • Severe side effects such as extreme dizziness, blurred vision, or difficulty speaking 3

Annual clinical review is recommended to assess compliance, bleeding patterns, and symptom control, with no routine laboratory monitoring required unless specific symptoms arise. 2

Bottom Line

Your provider has prescribed continuous progesterone specifically to avoid monthly periods while maintaining complete endometrial protection. 2, 5 This is a standard, evidence-based approach that is preferred by many women who wish to remain amenorrheic during hormone therapy. The absence of periods on this regimen is the intended therapeutic outcome, not a cause for concern. 6, 5

References

Guideline

Hormone Replacement Therapy Regimens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lowest Dose of Progesterone for Hormone Replacement Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The impact of micronized progesterone on the endometrium: a systematic review.

Climacteric : the journal of the International Menopause Society, 2016

Research

Oral micronized progesterone.

Clinical therapeutics, 1999

Research

Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol.

Climacteric : the journal of the International Menopause Society, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.